Transforming Toxicology Data into Enduring Knowledge: Acute Outcomes and Chronic Benefits of SEND Data Submission
Free
- Length
- 1 hr
- Platform
- Zoom
- Topic
- Medical & Clinical
About this webinar
Hosted by the SOT Biotechnology Specialty Section, Drug Discovery Toxicology Specialty Section, and Regulatory and Safety Evaluation Specialty Section
SEND data submission is often viewed as a regulatory obligation, yet its value extends well beyond compliance. In the near term, SEND delivers acute outcomes through improved data quality, greater study transparency, and more efficient regulatory review. Over time, standardized datasets become durable scientific assets that support cross-study analyses, translational research, and emerging computational approaches. This presentation highlights how SEND enables the transformation of toxicology data into reusable knowledge that continues to generate value long after a study is completed. Attendees will gain perspective on the chronic benefits of SEND for data stewardship, scientific innovation, and maximizing insights from nonclinical studies.
Speakers
Stephanie Leuenroth-Quinn, PhD, Associate Director for Pharmacology and Toxicology, CDER/OND/IO US Food and Drug Administration
Kevin Snyder, PhD, Director of Nonclinical Innovation and Emerging Technologies, Certara



